Health
Oxford/AstraZeneca vaccine 80 per cent effective against B1.617.2 variant: UK study – Yahoo India News
London, May 22 (PTI) Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the…
London, May 22 (PTI) Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus.
The UK findings are said to be based on…
-
General24 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General23 hours agoAuthorities say charged man used false name to escape from Perth court
-
Noosa News23 hours agoSkybound Gymnastics owner and coach Wei Jun Lee charged with sexual assault of teenager
-
Noosa News21 hours agoChild sex offenders to be known in Queensland public registry